1. |
Spriet A, Simon P, Dupin-Spriet T. Methodology of clinical drug trials. New York: Karger, 1985: 14-15.
|
2. |
青蒿素结构研究协作组. 一种新型的倍半萜内酯—青蒿素. 科学通报, 1977, 22(3): 142.
|
3. |
Hesketh T, Zhu WX. Traditional Chinese medicine: one country, two systems. BMJ, 1997, 315(7100): 115-117.
|
4. |
陈可冀, 钱振淮, 张问渠, 等. 精制冠心片双盲法治疗冠心病心绞痛 112 例疗效分析. 中华心血管病杂志, 1982, 10(2): 85-89.
|
5. |
Tang JL, Zhan SY, Ernst E. Review of randomised controlled trials of traditional Chinese medicine. BMJ, 1999, 319(7203): 160-161.
|
6. |
李幼平, 李静, 孙鑫, 等. 循证医学在中国的起源与发展: 献给中国循证医学20周年. 中国循证医学杂志, 2016, 16(1): 2-6.
|
7. |
王永炎, 刘保延, 谢雁鸣. 应用循证医学方法构建中医临床评价体系. 中国中医基础医学杂志, 2003, 9(3): 17-23.
|
8. |
陈可冀, 宋军. 循证医学的提出对中西医结合的启发. 中国中西医结合杂志, 1999, 19(11): 643.
|
9. |
张伯礼. 辨证论治与循证医学. 中国循证医学杂志, 2002, 2(1): 1-3.
|
10. |
李幼平, 刘鸣. 循证医学与中医药现代化. 中国中医药信息杂志, 1999, 8(12): 14-16, 32.
|
11. |
张晓雨, 陈诗琪, 李承羽, 等. 循证中医药学理论研究与应用实践. 中国循证医学杂志, 2018, 18(1): 86-91.
|
12. |
Shang H, Zhang J, Yao C, et al. Qi-shen-yi-qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial. Evid Based Complement Alternat Med, 2013, 2013: 1-9.
|
13. |
刘建平. 循证医学. 人民卫生出版社, 2012.
|
14. |
刘建平, 商洪才. 循证中医药. 人民卫生出版社, 2018.
|
15. |
Zhang X, Tian R, Yang Z, et al. Quality assessment of clinical trial registration with traditional Chinese medicine in WHO registries. BMJ Open, 2019, 9(2): e025218.
|
16. |
Cheng CW, Wu TX, Shang HC, et al. CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration. Ann Intern Med, 2017, 167(2): W7-W20.
|
17. |
Liu Z, Liu Y, Xu H, et al. Effect of electroacupuncture on urinary leakage among women with stress urinary incontinence: a randomized clinical trial. JAMA, 2017, 317(24): 2493-2501.
|
18. |
Zhao L, Chen J, Li Y, et al. The long-term effect of acupuncture for migraine prophylaxis: a randomized clinical trial. JAMA Intern Med, 2017, 177(4): 508-515.
|
19. |
Liu Z, Yan S, Wu J, et al. Acupuncture for chronic severe functional constipation: a randomized trial. Ann Intern Med, 2016, 165(11): 761-769.
|
20. |
Wang C, Cao B, Liu QQ, et al. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza. Ann Intern Med, 2011, 155(4): 217-225.
|
21. |
Li X, Zhang J, Huang J, et al. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin Capsules in patients with chronic heart failure. J Am Coll Cardiol, 2013, 62(12): 1065-1072.
|
22. |
Lu Z, Kou W, Du B, et al. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. Am J Cardiol, 2008, 101(12): 1689-1693.
|
23. |
Song Y, Yao C, Yao Y, et al. XueBiJing injection versus placebo for critically Ⅲ patients with severe community-acquired pneumonia: a randomized controlled trial. Crite Care Med,, 2019, 47(9): e735-e743.
|
24. |
王忠, 王永炎. 中药上市后临床再评价研究. 中国中药杂志, 2007, 32(1): 84-86.
|
25. |
杨薇, 谢雁鸣, 王永炎. 中医药临床实效研究—中药注射剂注册登记式医院集中监测方案解读. 中国中药杂志, 2012, 37(18): 2683-2685.
|
26. |
赵晨, 田贵华, 王燕平, 等. 涵盖科学观与人文观的循证医学发展—兼谈循证中医药学科的未来前景. 中国循证医学杂志, 2019, 19(2): 232-237.
|
27. |
Ahn K. The worldwide trend of using botanical drugs and strategies for developing global drugs. BMB Rep, 2017, 50(3): 111-116.
|
28. |
杨瑾, 加茂智嗣, 能濑爱加. 汉方药在日本的发展现状. 中草药, 2016, 47(15): 2771-2774.
|
29. |
中华中医药学会. 中医药重大科学问题和工程技术难题. 中医杂志, 2019, 60(12): 991-1000.
|